BioNexus Becomes First Nasdaq-Listed Firm To Adopt Ethereum Treasury
March 6, 2025
Medical technology company BioNexus Gene Lab has become the first NASDAQ-listed firm to adopt Ethereum as a strategy reserve asset.
Search
RECENT PRESS RELEASES
Related Post